Transforming the landscape of colorectal cancer treatment with immunotherapy: Evolution and future horizons
Colorectal cancer (CRC) continues to be one of the most prevalent and lethal cancers worldwide.Over the past decades, immune checkpoint att nighthawk hotspot inhibitors (ICIs) have shown to significantly improve patient outcomes in mismatch repair-deficient metastasized CRC.However, widening the scope of this novel treatment modality has been the o